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DIALYSIS – TRANSPLANTATION
Ethnicity and survival on dialysis in west London
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Ethnicity and survival on dialysis in west London.
Background. Indo-Asian and Afro-Caribbean patients have
higher rates of renal failure and requirement for renal replace-
ment therapy than the general population in the UK. Despite
this, information regarding survival on dialysis is limited.
Methods. The incident hemodialysis population of a large
west London renal service was reviewed from 1996 to 2001 (N =
465).
Results. The cohort’s ethnic background was Indo-Asian
(30.8%), Caucasian (49%), Afro-Caribbean (18.3%), and other
(1.9%). Indo-Asians and Afro-Caribbeans were younger than
Caucasian patients, with a higher rate of diabetes mellitus. Sur-
vival on hemodialysis for Indo-Asians was 97.5% and 81.6% at
1 and 3 years, respectively, compared with 92.7% and 75.2% for
Caucasians, and 97.5% and 85.3% for Afro-Caribbeans (P =
nonsignificant). Dialysis adequacy was observed to be associ-
ated with survival. Patients with mean single pool Kt/V of over
1.4 had survival of 90.6% and 74.8% at 2 and 5 years, respec-
tively, compared with 74.0% and 42.9% for those with Kt/V
less than 1.4 (P < 0.001). There were significantly more pa-
tients in the Indo-Asian cohort with a mean Kt/V of 1.4 or
over (87.4%) compared with Caucasians (57.6%) and Afro-
Caribbeans (52.4%), and the benefit of higher Kt/V was seen in
all ethnic groups. In a multivariate analysis of factors including
Kt/V over 1.4, age, diabetic status, gender, and ethnicity, Indo-
Asian or Afro-Caribbean ethnicity did not confer a survival
disadvantage. The strongest predictors of survival were age and
dialysis adequacy.
Conclusion. Indo-Asian and Afro-Caribbean hemodialysis
patients have survival comparable to Caucasians despite a
higher burden of diabetes.
The United Kingdom (UK) has an ethnic minority pop-
ulation of 4.6 million (8% of the total population), half of
which originates from the Indian subcontinent [1]. How-
ever, almost 8% of all new patients, and 7% of existing
patients on renal replacement therapy are Indo-Asian [2],
twice the percentage expected based on the proportion
of Indo-Asians in the general population. The predispo-
sition of this ethnic group to renal disease has previously
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been well described [3–5]. As the relatively young Indo-
Asian population ages, there will be an increasing burden
on renal services in areas with large non-white communi-
ties [6, 7]. A similar problem exists in the Afro-Caribbean
community, which contributes 8% of existing patients on
dialysis [2]. This issue is particularly relevant to London,
where 45% of the ethnic minority population resides [1].
Despite the breadth of the problem, data regarding the
short- and long-term outcome of ethnic minorities on re-
nal replacement therapy in the UK remain scarce.
Different outcomes for patients who are Indo-Asian,
Afro-Caribbean, or from other ethnic minorities can be
suspected on the basis of race-specific differences in pop-
ulation demographics, patterns of pathology, perceptions
of health and disease, and varying access to services.
Data from the United States [8, 9] and Canada [10] have
suggested that among dialysis patients, ethnic minorities
have superior dialysis outcomes and survival to white
Caucasians. The possibility of such differences in the UK
dialysis population has not yet been defined.
In the west London districts of Brent and Harrow,
Indo-Asians contribute almost 30% of the resident popu-
lation [1]. St. Mary’s Hospital provides a large proportion
of the adult renal services to this area. This study reviews
the impact of ethnicity within our population over a five-
year period.
METHODS
We assessed the incident dialysis population from Jan-
uary 1996 to September 2001. Only patients commencing
renal replacement therapy for the first time were included
to avoid comparing new patients and those with prior
history of treatment for end-stage renal failure. Thus, pa-
tients with failed renal transplants, or those who changed
from another dialysis modality were excluded. Patients
with acute renal failure were not included. We employed
a 90-day rule, whereby patients who died or ceased dial-
ysis within 90 days were excluded. This is in keeping with
the U.S. Renal Data System (USRDS), which includes
patients from 90 days onward [8], and the UK Renal
Registry, which reports data for both 0 to 90 days and
after 90 days to allow comparisons with other databases,
such as USRDS [2]. All patients were followed up
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Table 1. Patient characteristics
Indo-Asian N = 143 Caucasian N = 228 Afro-Caribbean N = 85 Other N = 9
Age years (mean ± SD) 55.6 ± 15 59.6 ± 16 53.0 ± 17 59.0 ± 16
Over 65 years % 29.3 43.8 24.7 44.4
Male % 57.3 65.8 58.8 66.7
Diabetic % 39.9 28.5 34.1 11.1
Months on dialysis (mean ± SD) 28.4 ± 18 27.1 ± 17 29.3 ± 19 30.8 ± 23
Dialysis adequacy
Kt/V less than 1.2 % 0.7 10.4 9.5 0
Kt/V 1.2–1.4 % 11.9 32.0 38.1 12.5
Kt/V ≥ 1.4 % 87.4 57.6 52.4 87.5
Status at end of follow-up
On hemodialysis % 77.0 60.5 74.1 33.0
Transplanted % 8.4 13.6 8.2 45.0
Death % 11.9 21.1 17.6 22.0
On peritoneal dialysis % 2.1 0.5 0 0
Transferred % 0.7 4.4 0 0
to December 31, 2001, with mean follow-up time of
35 months (3.2–71.8).
Age, gender, diabetic status, cause of end-stage re-
nal failure, dialysis start date, cause of death, and status
at the end of follow-up was recorded for each patient.
In keeping with Census 2001 ethnic classification [1],
patients were categorized into the following four eth-
nic groups: Caucasian, Indo-Asian (Indian, Pakistani,
and Bangladeshi), Afro-Caribbean (black African,
Caribbean), and Other.
Patients with renal impairment are referred by gen-
eral practitioners and physicians from the community and
hospital system, and are closely followed in pre-dialysis
clinics. The suitability of patients for dialysis is assessed
on an individual basis by a multidisciplinary team, led by
the nephrologist. Acceptance for maintenance dialysis in
our unit is in accordance with the published recommen-
dations and guidelines of the UK Renal Association [20].
In particular, there is no specific age cut-off for access
to dialysis. The majority of patients on renal replacement
therapy at St. Mary’s Hospital are on hemodialysis due to
ready access to hemodialysis facilities both in-center and
through several satellite units. Although all patients are
offered a choice of dialysis modality, hemodialysis is gen-
erally the preferred option, and the number of patients
suitable for peritoneal dialysis who choose this option is
small.
Hemodialysis was undertaken thrice weekly at St.
Mary’s Hospital or one of three satellite centers. Until
2000, dialysis adequacy was assessed four times per year
using the Sargent and Gotch method [11], and dialysis
prescription was adjusted to achieve a single-pool dialy-
sis dose (Kt/V) of 1.2 or more. Thereafter, adequacy was
measured monthly using the Daugirdas method [12], and
our unit policy was to achieve a Kt/V of 1.4 or greater.
For the purpose of analysis, mean Kt/V over the pe-
riod of observation was determined. Peritoneal dialysis
was either continuous ambulatory or automated dialysis,
with a target Kt/V of 2.0 or more. Diagnosis of peritoni-
tis was based on dialysate white cell count and culture
findings.
Statview for Windows (version 5.0, SAS Institute, Cary,
NC, USA) was used for statistical analyses. Groups
were compared using t test and chi-square analysis. The
Kaplan-Meier method with the log rank test was used
for survival analysis. Patients were censored at transplan-
tation, transfer to another unit and consequent loss of
follow-up, change to peritoneal dialysis, or upon reach-
ing the end of the study period. Multivariate analysis was
performed using Cox regression model analysis. A signif-
icance level of 5% was used for all analyses.
RESULTS
Hemodialysis
Four hundred and seventy-four patients commenced
hemodialysis during the study period. Nine patients were
excluded because they did not remain on hemodialysis for
more than 90 days. Of these, 3 patients died within 90 days,
2 changed to peritoneal dialysis, 3 were transplanted, and
1 transferred from our unit. Details of the final cohort
of 465 patients are shown in Table 1. Indo-Asians con-
tributed to 30.8% of the dialysis population. There were
only 9 patients of other ethnicity. These have not been
analyzed further as a separate group. Caucasian patients
were older than either Indo-Asian or Afro-Caribbean pa-
tients, and had a higher percentage of patients aged over
65 years (P < 0.02), while the non-white groups were sim-
ilar in age (P = NS). Of 110 patients who were aged over
70 years at commencement of dialysis, 61.8% were Cau-
casian. The gender distribution was similar between all
groups (P = NS), and 32.7% of the entire patient group
was diabetic (type I or type II). Indo-Asians had a sig-
nificantly higher rate of diabetes when compared with
Caucasians (P < 0.03), but not significantly higher than
Afro-Caribbeans. Mean single pool Kt/V of over 1.4 was
observed in 66.5% of the cohort. A higher rate of Kt/V
of 1.2 to 1.39 and over 1.4 was seen in Indo-Asians when
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Table 2. Causes of end-stage renal failure
Indo-Asian Caucasian Afro-Caribbean
Cause of ESRF % % %
Diabetic nephropathy 31.5 22.8 30.6
Small smooth kidneys 25.2 11.4 28.2
Glomerulonephritisa 12.6 17.1 14.1
Renovascular 7.7 14.9 0.0
Otherb 6.3 7.5 4.7
Tubulo-interstitial nephritis 4.9 1.8 1.2
Hypertension 4.2 4.8 5.9
Urologicalc 2.1 7.0 10.6
Polycystic Kidneys 2.8 7.0 1.2
N/Ad 2.8 5.7 3.5
aGlomerulonephritis: IgA nephropathy, membranous nephropathy, focal
and segmental glomerulosclerosis, lupus nephritis, vasculitis, fibrillary glomeru-
lonephritis, antiglomerular basement membrane disease, and HIV-associated
nephropathy.
bOther: cortical necrosis, amyloidosis, sickle cell disease, hemolytic uremic
syndrome, scleroderma, calcineurin inhibitor toxicity, sarcoidosis, multiorgan
failure, reflux nephropathy, analgesic nephropathy.
cUrologic: renal cell carcinoma, nephrectomy for any reason, obstructive
uropathy, and renal calculi.
dN/A, data not available.
compared with both Caucasians and Afro-Caribbeans
(P < 0.001). There was no statistical difference in the per-
centage of patients transplanted from each ethnic group.
Cause of end-stage renal failure
The cause of end-stage renal failure for each ethnic
group is shown in Table 2. The incidence of diabetic
nephropathy, glomerulonephritis, and hypertensive
nephropathy was not significantly different between
groups. Indo-Asian patients had a higher rate of tubu-
lointerstitial nephritis (P < 0.05). Patients presenting
end-stage with small kidneys were more common in
the ethnic minority groups compared with Caucasians
(P < 0.001). Renovascular disease was significantly more
common in Caucasians than Indo-Asians (P < 0.05)
and Afro-Caribbeans (P < 0.001). Urologic problems
were more common in Afro-Caribbean and Caucasian
patients than Indo-Asians (P < 0.01).
Patient survival according to ethnicity
Patient survival on hemodialysis was similar between
ethnic groups at 1, 2, and 3 years (Fig. 1). At 5 years,
patient numbers were small, but again, no significant dif-
ference in survival was found. In multivariate analyses
including factors such as age, gender, diabetic status, and
Kt/V, Indo-Asian ethnicity (vs. non-Asian) conferred a
relative risk of death at 3 years of 1.2 (P = 0.52, CI 0.65–
2.3). Afro-Caribbean ethnicity (vs. non Afro-caribbean)
conferred a relative risk of 0.61 (P = 0.21, CI 0.29–1.3).
Causes of death
Eighty-two patients died during the period of follow-
up. Cardiac or peripheral vascular disease was the lead-
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Fig. 1. Cumulative survival on hemodialysis according to ethnic back-
ground.
Table 3. Cause of death on hemodialysis according to ethnicity
Indo-Asian Caucasian Afro-CaribbeanAll deaths
% N % N % N %
Vascular 43 9 52.9 22 46.9 3 18.8
Sepsis 17 3 17.6 6 12.7 5 31.3
Malignancy 11 0 0.0 6 14.9 2 12.5
GI Bleed 5 2 11.8 0 0 1 6.2
Other 2 1 5.9 0 0 1 6.2
Unknown 22 2 11.8 12 25.5 25 25
ing cause of death on dialysis (Table 3). There was no
significant difference in cause of death based on ethnic-
ity, although the rate of death from vascular disease was
observed to be lower in Afro-Caribbean patients.
Dialysis adequacy
Dialysis adequacy was found to be a predictor of pa-
tient survival. Patients who achieved the target mean
Kt/V of 1.4 or more had significantly better survival than
those with Kt/V of below 1.4 (96.4%, 90.6%, 84.0%, and
74.8% vs. 91.3%, 74.0%, 66.9%, and 42.9% at 1, 2, 3,
and 5 years, respectively, P < 0.001). Thirty-two patients
(7.0%) were unable to achieve a consistent Kt/V of over
1.2 due to access difficulties, large body habitus, noncom-
pliance with dialysis hours, and intercurrent illness. A
small number of these patients were not aggressively dia-
lyzed on compassionate grounds due to advanced age and
comorbidity. To exclude the possibility that this group of
patients was mainly responsible for the poorer survival of
patients with Kt/V less than 1.39, further analysis was un-
dertaken of 121 patients (33.4%) with Kt/V greater than
or equal to 1.2, but below 1.4. Survival remained poorer
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in these patients (93.1%, 75.8%, 65.9%, and 42.2% at 1,
2, 3, and 5 years, respectively, P < 0.001).
Caucasian patients with Kt/V over 1.4 had superior
survival compared to those with Kt/V under 1.4 (82.0%
vs. 65.2% at 3 years, P = 0.004). Few Indo-Asian pa-
tients (N = 17) had Kt/V below 1.4, which limited sur-
vival analysis. At 2 years, survival of Indo-Asian pa-
tients with Kt/V greater than 1.4 was 89.8% compared
with 50.0% for those below 1.4. However, in the Afro-
Caribbean group the survival difference between patients
with higher Kt/V versus lower Kt/V was less pronounced
(93.4% vs. 73.7% at 3 years, P = 0.048). Analysis of all
patients who achieved a Kt/V 1.4 or more revealed sur-
vival up to 3 years was similar between ethnic groups and
male and female patients.
In a multivariate model including age, gender, ethnic-
ity, and diabetic status, Kt/V over 1.4 was positive pre-
dictor of survival, conferring a relative risk of death at
3 years of 0.38 (P = 0.001, CI 0.22–0.68).
Diabetic status
Over one third of Indo-Asian and Afro-Caribbean
patients were diabetic, and diabetic nephropathy was
the most common cause of renal failure in all ethnic
groups. At 3 years, there was a trend toward worse sur-
vival of Indo-Asian diabetics compared with nondiabet-
ics (68.3% vs. 88.7%, P = 0.05). Analysis of the entire
cohort, regardless of ethnicity, confirmed a trend toward
worse survival in diabetic patients at 3 years, which be-
came statistically significant at 5 years (69.5% vs. 50.5%;
P = 0.02). However, in multivariate analysis after adjust-
ing for age, gender, dialysis adequacy, and ethnic back-
ground, diabetes did not confer a significantly increased
risk of death at 3 years (RR 1.3, P = 0.35, CI 0.76–2.2).
Age at start of dialysis
Patients commencing dialysis when aged 65 or over had
worse 5-year survival than those who started dialysis at a
younger age (48.3% vs. 76.6% at 5 years; P < 0.0001). This
effect of age was not seen when Indo-Asians were ana-
lyzed as a separate group (over 65 vs. under 65; 77.6%
vs. 83.2%; P = 0.21 at 3 years). This is most likely due
to small numbers of patients over 65 years of age (N =
42) in the Indo-Asian group, reflecting the younger Indo-
Asian population in the general community. In multivari-
ate analysis, age over 65 at start of dialysis conferred a 2.0
times higher relative risk of death on hemodialysis (P =
0.006, CI 1.2–3.4).
Peritoneal dialysis
From January 1996 until December 2001, 43 patients
commenced peritoneal dialysis as their first form of renal
replacement therapy. The cohort consisted of 23 Cau-
casians, 19 Indo-Asians, and 1 Afro-Caribbean patient.
There was no difference in mean age, gender distribu-
tion, or rate of diabetes between Indo-Asian and non-
Asian patients. The main causes of end-stage renal failure
were diabetes (18.6%) and glomerulonephritis (14%),
although 46.5% of patients presented with small kid-
neys with no diagnosis evident. There was no differ-
ence in cause of renal failure between ethnic groups. The
mean (±SD) duration on peritoneal dialysis was 29.7 ±
17.0 months for Indo-Asians and 23.8 ± 17.0 months
for non-Asians (P = 0.26). At the end of follow-up,
12 patients remained on peritoneal dialysis, 11 were
transplanted, and 18 patients changed to hemodialysis.
Twenty-three patients experienced at least one episode
of peritonitis, with equal rates in each ethnic group. The
main reasons for changing to hemodialysis were a single
severe episode of peritonitis or recurrent peritonitis (N =
10), or ultrafiltration failure (N = 5). Two patients died,
one due to peritonitis, the other with an out-of-hospital
collapse. There was no difference in outcome between
ethnic groups, although both deaths on peritoneal dialysis
were in Caucasian patients. An overall survival analysis
of all patients (peritoneal dialysis and hemodialysis) re-
vealed outcomes similar to those seen in the hemodialysis
group alone (data not shown).
DISCUSSION
Indo-Asians in the UK have a 3 to 6 times higher age-
adjusted relative risk of end-stage renal failure compared
with white Caucasians [3, 5]. A review of the London
Thames area population in the early 1990s [4] revealed
the relative risk of renal replacement therapy for Asians
compared with white patients aged 16 to 54 years was
3.0, and rose with age to 8.0 for those aged over 65 years.
A similarly alarming picture is seen nationwide [6]. The
death rate from renal disease for Indo-Asians in the gen-
eral UK population is over 3 times the national rate [7].
Patterns of renal pathology are different in Indo-Asians
compared with Caucasians, with higher rates of diabetic
nephropathy, interstitial nephritis, and focal segmental
glomerulosclerosis [5, 13, 14]. The cause of renal failure
is often unknown.
Knowledge of outcomes of renal replacement ther-
apy in ethnic minorities has been very limited. A study
of Indo-Asians from Bradford, UK, raised the possibil-
ity of worse long-term outcomes after renal transplanta-
tion in this group compared with non-Asians, due to a
higher rate of death with graft function [15]. Data from
our own unit [16] have suggested equivalent graft and
patient outcomes in Indo-Asians, at least up to 3 years
post-transplant. Information regarding ethnicity and dial-
ysis outcomes has suggested the opposite situation. The
United States Renal Data System (USRDS) has reported
differences in survival between white and non-white
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patients on dialysis, with higher crude mortality rates
among white patients [8]. However, the majority of non-
white patients in the U.S. are African American or His-
panic. “Asian” Americans are a heterogeneous ethnic
group of Oriental and southeast Asians, as well as those
from the Indian subcontinent [9], and it is not known if
differences exist within these ethnic subgroups. The UK
Renal Registry has reported a trend toward superior sur-
vival at 1 year in non-white patients in the 2000 incident
renal replacement therapy cohort (dialysis and transplan-
tation) [2], but longer-term data and ethnic breakdown
are not available. There has been one UK-based study
relating to peritoneal dialysis in 70 patients, half of who
were Indo-Asian [15]. Survival analysis was limited to the
absolute death rate, which, at 2 years, was not different
between ethnic groups.
The Toronto Regional Dialysis Registry [10] has, thus
far, provided the most detailed analysis of dialysis survival
of Indo-Asians in a western country. This study of almost
4000 patients included 322 south Asians of similar eth-
nic background to Indo-Asians in our study. It reported
worse survival and a relative risk of death of 1.36 (CI
1.07–1.73) for Caucasians compared with south Asians.
This was despite a higher rate of diabetes in non-whites,
and was independent of differences in cardiovascular bur-
den and transplantation. It provides further support for
the hypothesis that important race-related differences do
exist in dialysis cohorts, and need to be searched for in
our local population.
The problem of renal failure also extends to Afro-
Caribbean patients. In the UK, this ethnic group has rates
of renal disease and dialysis dependency that are similar
to that for Indo-Asians, and much higher than the general
non-ethnic population [2, 4], but as with Indo-Asians, lit-
tle is known about dialysis outcome. The largest body of
knowledge arises from African American patients, who
are reported in the USRDS registry as having better long-
term survival rates than white patients [8].
This is the first UK-based study to assess the influence
of ethnicity on hemodialysis survival. Our findings reas-
sure us that Indo-Asians and Afro-Caribbeans have ex-
cellent medium-term survival, similar to Caucasians. Up
to 3 years, all ethnic groups have survival above 75%.
Longer follow-up is required before further conclusions
can be made about survival beyond this point. Patient sur-
vival on hemodialysis in our patient cohort is consistent
with survival reported elsewhere for the UK, keeping in
mind that our study cohort consisted of a large non-white
ethnic group, that patients with prior history of any re-
nal replacement therapy were specifically excluded, and
that a 90-day rule was applied. The UK Renal Registry
reported 84% 1-year survival for all prevalent patients in
England and Wales established on hemodialysis or peri-
toneal dialysis for more than 90 days [2]. The adjusted
survival of incident patients on hemodialysis after 90 days
was 80.8% at 1 year. Data regarding ethnicity were avail-
able for only 56% of patients in the registry, and therefore,
further analysis of survival with ethnic divisions has not
been made.
The good survival of Indo-Asian and Afro-Caribbean
dialysis patients is surprising given the burden of diabetes
mellitus and consequent cardiovascular risk that could be
predicted for these groups. UK Indo-Asians aged 30 to
64 years with diabetes are more likely to die a cardiovas-
cular death than non-Asians [18]. Diabetes in UK dialy-
sis patients of all ethnic backgrounds is associated with a
higher rate of cardiovascular disease and death, regard-
less of age [2]. Almost 40% of our Indo-Asian and 34%
of our Afro-Caribbean dialysis population had diabetes.
Diabetic nephropathy was the cause of renal failure in
31% of patients, which is slightly higher than the previ-
ously reported rate of 21% in Asians in England on renal
replacement therapy [6]. In our cohort of patients, dia-
betics had worse survival at 5 years in univariate analysis.
This is despite the fact that 74% of the diabetic popula-
tion were from non-Caucasian backgrounds, and there-
fore, were younger, and, in the case of Indo-Asians, had
better dialysis adequacy. After multivariate analysis in-
cluding these factors of ethnicity, age, and Kt/V, diabetes
did not appear to significantly increase the relative risk
of death. However, we did not adjust for cardiovascular
comorbidity and the presence of related risk factors such
as hypertension, body mass index, smoking, and dyslipi-
demia, which could vary in each ethnic group. We did note
that cardiovascular disease was the most common cause
of death on dialysis in both Caucasians and Indo-Asians,
a finding consistent with UK data [2].
As expected, age over 65 at the start of dialysis was
shown to be a strong negative predictor of survival. This
effect was seen predominantly in the Caucasian popula-
tion, as we found significantly fewer patients aged over 65
in the non-Caucasian groups. Ethnic and migrant commu-
nities in the general population tend to be younger than
Caucasians [1] and deliver younger patients for renal re-
placement therapy [10]. The age distribution within eth-
nic groups in our cohort is consistent with other studies.
Pei et al [10] reported mean ages for south Asians (com-
parable to UK Indo-Asians) and blacks (comparable to
UK Afro-Caribbeans) on dialysis of 52.7 and 50.6 years,
respectively, which are slightly younger than the mean
ages of our patient cohort. As with our study, these ethnic
groups on dialysis were found to be significantly younger
than Caucasian groups. It is likely that as ethnic popula-
tions age in the community, their renal replacement ther-
apy cohorts will also age, and this may have an influence
on comorbidity and survival.
Dialysis adequacy was found to be associated with
patient mortality. Guidelines for hemodialysis adequacy
suggest a minimum target Kt/V of 1.2, preferably pre-
scribing a higher dose to ensure adequacy does not fall
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below this minimum [19, 20]. Just over 7% of our patient
population had a mean single pool Kt/V below 1.2, and
only one of these patients was Indo-Asian. A significantly
higher proportion of Indo-Asian patients had mean Kt/V
of greater than 1.4 compared with other ethnic groups,
perhaps reflecting smaller body size or muscle mass, or
lower protein intake. Higher Kt/V and urea reduction
ratios have been found elsewhere in Asian Americans
(including Indo-Asians, as well as other Asians), inde-
pendent of differences in body mass [9]. The relation-
ship between dialysis dose and mortality is currently a
contentious issue. A positive link between higher dialysis
delivery and improved survival was not confirmed by the
recent HEMO study [21]. In our patient cohort, Kt/V
above 1.4 did appear to be associated with better sur-
vival, although causality has not been established. There
is some evidence to suggest the relationship between dial-
ysis dose and survival may not be uniform in all ethnic
groups. For example, African American patients have
better survival than other ethnic groups on dialysis in
the United States, despite lower Kt/V and urea reduction
ratios [22, 23]. In our study, we found the benefit of a
higher Kt/V on survival was less pronounced in the Afro-
Caribbean population, although still significant. These
differences between ethnic groups warrant further study
of parameters that influence adequacy and survival, such
as dialysis hours, vascular access function, lean body mass,
protein intake, hemoglobin, and serum albumin, which
were not included in our study.
CONCLUSION
Using data from a large patient cohort derived from a
population with a strong ethnic minority presence, we
have shown that Indo-Asian and Afro-Caribbean pa-
tients have good survival on hemodialysis, comparable
to Caucasians. This is despite a higher prevalence of di-
abetes, and is due in part to the younger age of ethnic
populations. Indo-Asian patients achieve better dialysis
adequacy than non-Asians, although the influence of ad-
equacy on survival in different ethnic groups is unclear
and merits further investigation.
Reprint requests to Shilpanjali Prasad, Transplant Immunology Lab-
oratory, 6th Floor, Basil Hetzel Institute, The Queen Elizabeth Hospital,
Woodville, SA, 5011 Australia.
E-mail: shilpa.prasad@nwahs.sa.gov.au
REFERENCES
1. NATIONAL STATISTICS WEB SITE: Census 2001, www.statistics.gov.uk
2. ANSELL D, FEEST T (editors): UK Renal Registry Fifth Annual Report
2002, Bristol, UK, UK Renal Registry, 2002
3. LIGHTSTONE L, REES AJ, TOMSON C, et al: High incidence of end-
stage renal disease in Indo-Asians in the UK. Q J Med 88:191–195,
1995
4. RODERICK P, JONES I, RALEIGH VS, et al: Population need for renal
replacement therapy in Thames regions: Ethnic dimension. BMJ
309:1111–1114, 1994
5. BALL S, LLOYD J, CAIRNS T, et al: Why is there so much end-stage
renal failure of undetermined cause in UK Indo-Asians? Q J Med
94:187–193, 2001
6. RODERICK PJ, RALEIGH VS, HALLAM L, MALLICK NP: The need and
demand for renal replacement therapy in ethnic minorities in Eng-
land. J Epidemiol Community Health 50:334–339, 1996
7. RALEIGH VS: Diabetes and hypertension in Britain’s ethnic minori-
ties: Implications for the future of renal services. BMJ 314:209–213,
1997
8. U.S. RENAL DATA SYSTEM: USRDS 2002 Annual Data Report: Atlas
of End-Stage Renal Disease in the United States, Bethesda, MD,
National Institutes of Health, National Institute of Diabetes and
Digestive and Kidney Diseases, 2002
9. FRANKENFIELD DL, RAMIREZ SPB, MCCLELLAN WM, et al: Differ-
ences in intermediate outcomes for Asian and non-Asian adult
haemodialysis patients in the United States. Kidney Int 64:623–631,
2003
10. PEI YPC, GREENWOOD CMT, CHERY AL, WU GG: Racial differ-
ences in survival of patients on dialysis. Kidney Int 58:1293–1299,
2000
11. SARGENT J: Control of dialysis by a single pool urea model: The
National Cooperative Dialysis Study. Kidney Int 23(Suppl 13):S19–
S25, 1983
12. DAUGIRDAS JT: Simplified equations for monitoring Kt/V, PCRn,
eKtV and ePCRn. Adv Ren Replace Ther 2:295–304, 1995
13. PAZIANAS M, EASTWOOD JB, MACRAE KD, PHILLIPS ME: Racial ori-
gin and primary renal diagnosis in 771 patients with end-stage renal
disease. Nephrol Dial Transplant 6:931–935, 1991
14. BALL S, COOK T, HULME B, et al: The diagnosis and racial origin of 394
patients undergoing renal biopsy: An association between Indian
race and interstitial nephritis. Nephrol Dial Transplant 12:71–77,
1997
15. JEFFREY RF, WOODROW G, MAHLER J, et al: Indo-Asian experience
of renal transplantation in Yorkshire: Results of a 10-year survey.
Transplantation 73:1652–1657, 2002
16. PRASAD S, LOUCAIDOU M, VAN TROMP J, et al: Outcome of renal trans-
plantation in Indo-Asians is similar to non-Asians. Am J Transplant
3(Suppl 5):363, 2003
17. BAKEWELL A, HIGGINS R, EDMUNDS M: Nutrition, adequacy of dial-
ysis, and clinical outcome in Indo-Asian and White European pa-
tients on peritoneal dialysis. Q J Med 95:811–820, 2002
18. MATHER H, CHATURVEDI N, FULLER JH: Mortality and morbidity
from diabetes in South Asians and Europeans: 11 year follow up of
the Southall Diabetes Survey, London UK. Diabet Med 15:53–59,
1998
19. NATIONAL KIDNEY FOUNDATION: K/DOQI clinical practice guidelines
for hemodialysis adequacy, 2000. Am J Kidney Dis 37(Suppl 1):S7–
S64, 2001
20. RENAL ASSOCIATION STANDARD AND AUDITS SUBCOMMITTEE: Treat-
ment of Adults and Children with Renal Failure: Standards and Audit
Measures, 3rd ed., London, Royal College of Physicians, 2002
21. EKNOYAN G, BECK GJ, CHEUNG AK, et al: Effect of dialysis dose
and membrane flux in maintenance haemodialysis. N Engl J Med
347:3010–3019, 2002
22. OWEN WF JR, CHERTOW GM, LAZARUS JM, LOWRIE EG: Dose of
haemodialysis and survival: Differences by race and sex. JAMA
280:1764–1768, 1998
23. FRANKENFIELD DL, ROCCO MV, FREDERICK PR, et al: Racial/ethnic
analysis of selected intermediate outcomes for haemodialysis pa-
tients: Results from the 1997 ESRD Core Indicators Project. Am J
Kidney Dis 34:756–758, 1999
